RLX Releases Q2 2022 Financial Report on NASDAQ

Sep.21.2022
RLX Releases Q2 2022 Financial Report on NASDAQ
Chinese vaping company, RLX, reported a 12.1% decline in Q2 2022 revenues due to regulatory restrictions on store expansions.

RLX, a Chinese e-cigarette company, released its second-quarter financial report for 2022 on September 21 at 6:00 AM Eastern Time (18:00 Beijing Time) on NASDAQ. Below are the key takeaways compiled by 2FIRSTS.


Net income for the second quarter of 2022 was 2.2339 billion yuan ($333.5 million USD), a 12.1% decrease compared to the same period in 2021, which had a net income of 2.5414 billion yuan.


Reasons for the decrease: The company halted store expansions and new product releases during a transitional period to comply with regulatory requirements. The net profit for the second quarter of 2022, confirmed under the US Generally Accepted Accounting Principles (GAAP), was 441.6 million yuan, a 46.4% decrease compared to the same period in 2021, which saw a net profit of 824.3 million yuan.


The net profit for Q2 2022, unadjusted for GAAP standards, was 634.7 million yuan, a 2.6% decrease compared to 651.8 million yuan in the same period of 2021.


In the second quarter of 2022, the gross profit margin was 43.8%, compared to 45.1% during the same period in 2021.


Reasons for the decline: adjustment of product lines, increase in inventory, and impairment losses incurred in order to comply with regulatory requirements on properties, factories, and equipment.


In the second quarter of 2022, operating costs reached RMB 530.9 million (USD 79.3 million), representing a growth of 217.6% compared to the same period in 2021, where operating costs were RMB 167.2 million. The increase in operating costs was mainly due to a change in equity incentive expenses, with RMB 193.2 million (USD 28.8 million) in Q2 2022, compared to RMB 172.5 million in the same period last year.


In the second quarter of 2022, general and administrative expenses amounted to 290.7 million yuan (approximately 43.4 million US dollars), representing a 531.3% increase from the same period in 2021, which amounted to 46.1 million yuan. The significant increase was primarily due to increased compensation expenses based on stock and higher salaries and benefits.


In the second quarter of 2022, research and development expenses amounted to RMB 117.6 million (USD 17.6 million), compared to RMB 4.9 million in the same period last year. The increase was mainly due to compensation expenses, salary and welfare increases, and consulting fees.


In the second quarter of 2022, the operating revenue was 446.9 million yuan (66.7 million US dollars), a decrease of 54.4% compared to the same period in 2021, when it was 979.3 million yuan. However, interest income increased by double, from 160.7 million yuan in the same period in 2021 to 427.2 million yuan. Investment income also increased nearly twice, from 238.7 million yuan in the same period in 2021 to 406.3 million yuan.


As of the end of the second quarter of 2022, the cash and cash equivalents of the company stood at RMB 1.7091 billion, down 67.2% from the previous year's RMB 5.209 billion. Short-term deposits were RMB 5.315 billion, up 32.1% from the previous year's RMB 4.0221 billion.


As of the end of the second quarter of 2022, the total assets amounted to RMB 17.5163 billion, compared to RMB 16.3651 billion at the end of the previous year. The total liabilities were RMB 2.9084 billion, which is slightly higher than the RMB 2.8464 billion at the end of the previous year. The debt-to-asset ratio decreased from 17.4% at the end of the previous year to 16.6%.


According to the financial report, a subsidiary of Yooz, a Chinese e-cigarette brand, has been awarded a production license by the State Tobacco Monopoly Administration. The production quota for the license includes 15.05 million refillable e-cigarette devices, 328.7 million pod cartridges, and 6.1 million disposable e-cigarettes annually. The license is valid from July 18, 2022, to July 31, 2023.


Statement:


1. This article is intended only for internal industry research and exchange. It does not make any investment or brand recommendations. It is not intended to be used as a basis for any investment decisions. 2. The data and analysis conclusions cited in this article have not been confirmed in writing by the companies referenced. Please refer to the company's official publications for all data.


This article is an original piece created by 2FIRSTS Technology Co., Ltd. of Shenzhen. The copyright and permission to use it belong to the company, and no individual or organization is authorized to commercially reproduce, copy, or use it in any way that infringes upon the company's copyright without prior permission. Any violations of this will result in the company reserving the right to pursue legal action.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

XQS Rolls Out Two Beverage-Flavoured Nicotine Pouches in UK; Says Convenience Stores Are the Fastest-Growing Channel
XQS Rolls Out Two Beverage-Flavoured Nicotine Pouches in UK; Says Convenience Stores Are the Fastest-Growing Channel
Scandinavian Tobacco Group (STG) UK has added two beverage-inspired variants—Cola Lime and Fizzy Peach—to its XQS nicotine pouch range. Both come in an 8mg strength and are available exclusively via the Vape Supplier website, with a recommended retail price of £5.50.
Oct.29 by 2FIRSTS.ai
FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA’s launch of a web-based PMTA system signals faster reviews and, 2Firsts experts say, a possible inflection point for the U.S. e-cigarette market’s shift out of the grey zone.
Dec.04
Over 92,000 kg of Nicotine Products Seized at Ambassador Bridge
Over 92,000 kg of Nicotine Products Seized at Ambassador Bridge
The Canada Border Services Agency seized 92,270 kilograms of undeclared nicotine products at the Ambassador Bridge over four days, according to a social media post. The confiscated items included vapes, tins, and pouches. Officials stated the seizure helps prevent profits from reaching organized crime groups.
Dec.03 by 2FIRSTS.ai
Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade
Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade
California-based vape manufacturer Schwartz E-Liquid (USA Vape Lab) has sued the U.S. Food and Drug Administration (FDA) in federal court, alleging the agency unlawfully failed to issue a decision on its premarket application for flavored e-cigarette products for more than five years. The company is seeking a court order compelling the FDA to act within 90 days.
Nov.26 by 2FIRSTS.ai
New York AG Seeks to Shut Down Vape Shops, Ban Owners from Industry
New York AG Seeks to Shut Down Vape Shops, Ban Owners from Industry
New York Attorney General Letitia James has filed a petition seeking to permanently shut down two smoke shops and ban their owners from the vape industry for repeatedly selling illegal flavored vapes to minors and operating without valid licenses. The nearly 50-page complaint names Eysa Sharhan and Ahmed Mozeb and their stores — Pop-In Smoke & Vape LLC, Pufftopia LLC, and Royalty Tobacco LLC — accusing them of a “persistent pattern of illegal activity.”
Oct.24 by 2FIRSTS.ai
Canadian Media Investigation: BAT’s Nicotine Pouch ZONNIC Sparks Ongoing Controversy as Regulatory Gaps in Canada Come Under Scrutiny
Canadian Media Investigation: BAT’s Nicotine Pouch ZONNIC Sparks Ongoing Controversy as Regulatory Gaps in Canada Come Under Scrutiny
Canadian outlet Rebel News released a long-form video report examining Canada’s regulatory framework for nicotine pouches, market dynamics, and the approval process of ZONNIC, a product of BAT subsidiary Imperial Tobacco Canada. The report highlights issues involving youth access, regulatory gaps, black-market activity, retailer feedback, and company responses. This article summarizes key points based on the video.
Dec.02 by 2FIRSTS.ai